Cutting edge:: NKG2D is a costimulatory receptor for human naive CD8+ T cells

被引:150
|
作者
Maasho, K [1 ]
Opoku-Anane, J [1 ]
Marusina, AI [1 ]
Coligan, JE [1 ]
Borrego, F [1 ]
机构
[1] NIAID, Receptor Cell Biol Sect, Lab Allerg Dis, NIH, Rockville, MD 20852 USA
来源
JOURNAL OF IMMUNOLOGY | 2005年 / 174卷 / 08期
关键词
D O I
10.4049/jimmunol.174.8.4480
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
In humans, all alpha beta CD8(+) T cells express NKG2D, but in mouse, it is only expressed by activated and memory CD8(+) Tcells. We purified human naive CD8+ Tcells to show that NKG2D serves as a costimulatory receptor for TCR induced Ca2+ mobilization and proliferation. The resulting effector cells are skewed toward a type 1 phenotype and produce high levels of IFN-gamma and TNF-alpha NKG2D ligands, MHC class I chain-related (MIC)A, MICB, and UL16-binding proteins are expressed on the proliferating cells and NKG2D is down-regulated, The addition of the homeostatic cytokines IL-7 and IL-15 to the culture medium not only enhances proliferation but also counteracts the down-regulation of NKG2D, more so than the addition of IL-2. These results indicate that NKG2D can regulate the priming of human naive CD8+ Tcells, which may provide an alternative mechanism for potentiating and channeling the immune response.
引用
收藏
页码:4480 / 4484
页数:5
相关论文
共 50 条
  • [21] NKG2D signaling on CD8+ T cells represses T-bet and rescues CD4-unhelped CD8+ T cell memory recall but not effector responses
    Andrew Zloza
    Frederick J Kohlhapp
    Gretchen E Lyons
    Jason M Schenkel
    Tamson V Moore
    Andrew T Lacek
    Jeremy A O'Sullivan
    Vineeth Varanasi
    Jesse W Williams
    Michael C Jagoda
    Emily C Bellavance
    Amanda L Marzo
    Paul G Thomas
    Biljana Zafirova
    Bojan Polić
    Lena Al-Harthi
    Anne I Sperling
    José A Guevara-Patiño
    Nature Medicine, 2012, 18 : 422 - 428
  • [22] NKG2D signaling on CD8+ T cells represses T-bet and rescues CD4-unhelped CD8+ T cell memory recall but not effector responses
    Zloza, Andrew
    Kohlhapp, Frederick J.
    Lyons, Gretchen E.
    Schenkel, Jason M.
    Moore, Tamson V.
    Lacek, Andrew T.
    O'Sullivan, Jeremy A.
    Varanasi, Vineeth
    Williams, Jesse W.
    Jagoda, Michael C.
    Bellavance, Emily C.
    Marzo, Amanda L.
    Thomas, Paul G.
    Zafirova, Biljana
    Polic, Bojan
    Al-Harthi, Lena
    Sperling, Anne I.
    Guevara-Patino, Jose A.
    NATURE MEDICINE, 2012, 18 (03) : 422 - U184
  • [23] CD8+ T cells maintain killing of MHC-I-negative tumor cells through the NKG2D–NKG2DL axis
    Emily C. Lerner
    Karolina I. Woroniecka
    Vincent M. D’Anniballe
    Daniel S. Wilkinson
    Aditya A. Mohan
    Selena J. Lorrey
    Jessica Waibl-Polania
    Lucas P. Wachsmuth
    Alexandra M. Miggelbrink
    Joshua D. Jackson
    Xiuyu Cui
    Jude A. Raj
    William H. Tomaszewski
    Sarah L. Cook
    John H. Sampson
    Anoop P. Patel
    Mustafa Khasraw
    Michael D. Gunn
    Peter E. Fecci
    Nature Cancer, 2023, 4 : 1258 - 1272
  • [24] NKG2D expression by CD8+ T cells contributes to GVHD and GVT effects in a murine model of allogeneic HSCT
    Karimi, Mobin A.
    Bryson, Jerrod L.
    Richman, Lee P.
    Fesnak, Andrew D.
    Leichner, Theresa M.
    Satake, Atsushi
    Vonderheide, Robert H.
    Raulet, David H.
    Reshef, Ran
    Kambayashi, Taku
    BLOOD, 2015, 125 (23) : 3655 - 3663
  • [25] Cutting edge:: Expression of chemokine receptor CXCR1 on human effector CD8+ T cells
    Takata, H
    Tomiyama, H
    Fujiwara, M
    Kobayashi, N
    Takiguchi, M
    JOURNAL OF IMMUNOLOGY, 2004, 173 (04): : 2231 - 2235
  • [26] NKG2D signaling certifies CD8 T cells to become memory cells
    Perez, Cynthia
    Prajapati, Kushal
    Burke, Brianna
    Plaza-Rojas, Lourdes
    Alejandro Guevara-Patino, Jose
    JOURNAL OF IMMUNOLOGY, 2017, 198 (01):
  • [27] HCMV variants expressing ULBP2 modulate NKG2D expression and function on NK and CD8+ T cells
    Meyer, G.
    Siemes, R.
    Kuehne, J. F.
    Keil, J.
    Beushausen, K.
    Wagner, K.
    Steinbrueck, L.
    Borst, E. -M.
    Messerle, M.
    Falk, C. S.
    EUROPEAN JOURNAL OF IMMUNOLOGY, 2022, 52 : 371 - 371
  • [28] Silencing human NKG2D, DAP10, and DAP12 reduces cytotoxicity of activated CD8+ T cells and NK cells
    Karimi, M
    Cao, TM
    Baker, JA
    Verneris, MR
    Soares, L
    Negrin, RS
    JOURNAL OF IMMUNOLOGY, 2005, 175 (12): : 7819 - 7828
  • [29] NKG2D ligand expression in Crohn's disease and NKG2D-dependent stimulation of CD8+ T cell migration
    Vadstrup, Kasper
    Galsgaard, Elisabeth Douglas
    Jensen, Helle
    Lanier, Lewis L.
    Ryan, James C.
    Chen, Shih-Yu
    Nolan, Garry P.
    Vester-Andersen, Marianne Kajbaek
    Pedersen, Julie Steen
    Gerwien, Jens
    Jensen, Teis
    Bendtsen, Flemming
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2017, 103 (01) : 56 - 70
  • [30] IL-21 down-regulates NKG2D/DAP10 express on human NK and CD8+ T cells
    Burgess, SJ
    Marusina, AI
    Pathmanathan, I
    Borrego, F
    Coligan, JE
    JOURNAL OF IMMUNOLOGY, 2006, 176 (03): : 1490 - 1497